Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
This page is not indexed by search engines while we improve data quality.
Shilpa Medicare Ltd — Human Necessities
Shilpa Medicare Ltd holds 69 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Shilpa Medicare Ltd |
| Technology | Human Necessities |
| Patents in slice | 69 |
| Recent patents in slice | 12 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Shilpa Medicare Ltd to Human Necessities.
Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Recent filings
Latest patents from Shilpa Medicare Ltd in Human Necessities.
Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Related pages
Navigate to parent entity pages.